标题
Pharmacological treatment options for cryopyrin-associated periodic syndromes
作者
关键词
-
出版物
Expert Review of Clinical Pharmacology
Volume 10, Issue 8, Pages 855-864
出版商
Informa UK Limited
发表日期
2017-06-07
DOI
10.1080/17512433.2017.1338946
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Efficacy and safety of canakinumab in Schnitzler syndrome: A multicenter randomized placebo-controlled study
- (2017) Karoline Krause et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Safety of vaccinations in patients with cryopyrin-associated periodic syndromes: a prospective registry based study
- (2017) Veronika K. Jaeger et al. RHEUMATOLOGY
- Anakinra for Colchicine-Resistant Familial Mediterranean Fever: A Randomized, Double-Blind, Placebo-Controlled Trial
- (2017) Ilan Ben-Zvi et al. Arthritis & Rheumatology
- Bridging the Gap between the Clinician and the Patient with Cryopyrin-Associated Periodic Syndromes
- (2017) L. Cantarini et al. INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY
- Diagnostic criteria for cryopyrin-associated periodic syndrome (CAPS)
- (2016) Jasmin B Kuemmerle-Deschner et al. ANNALS OF THE RHEUMATIC DISEASES
- Rationale and study design for a phase I/IIa trial of anakinra in children with Kawasaki disease and early coronary artery abnormalities (the ANAKID trial)
- (2016) Adriana H. Tremoulet et al. Contemporary Clinical Trials
- Anakinra
- (2016) George Lazaros et al. Journal of Cardiovascular Medicine
- A Study to Investigate the Efficacy and Safety of an Anti-Interleukin-18 Monoclonal Antibody in the Treatment of Type 2 Diabetes Mellitus
- (2016) Elizabeth A. McKie et al. PLoS One
- Long-term safety profile of anakinra in patients with severe cryopyrin-associated periodic syndromes
- (2016) Torbjörn Kullenberg et al. RHEUMATOLOGY
- Brief Report: Severe Inflammation Following Vaccination AgainstStreptococcus pneumoniaein Patients With Cryopyrin-Associated Periodic Syndromes
- (2016) Ulrich A. Walker et al. Arthritis & Rheumatology
- Comparative Safety of Interleukin-1 Blockade With Anakinra in Patients With ST-Segment Elevation Acute Myocardial Infarction (from the VCU-ART and VCU-ART2 Pilot Studies)
- (2015) Antonio Abbate et al. AMERICAN JOURNAL OF CARDIOLOGY
- Recommendations for the management of autoinflammatory diseases
- (2015) Nienke M ter Haar et al. ANNALS OF THE RHEUMATIC DISEASES
- Treatment of two patients with generalized pustular psoriasis with the interleukin-1β inhibitor gevokizumab
- (2015) B. Mansouri et al. BRITISH JOURNAL OF DERMATOLOGY
- One week treatment with the IL-1 receptor antagonist anakinra leads to a sustained improvement in insulin sensitivity in insulin resistant patients with type 1 diabetes mellitus
- (2015) Edwin J.P. van Asseldonk et al. CLINICAL IMMUNOLOGY
- Efficacy and safety profile of anti-interleukin-1 treatment in Behçet’s disease: a multicenter retrospective study
- (2015) Giacomo Emmi et al. CLINICAL RHEUMATOLOGY
- The PYRIN Domain-only Protein POP1 Inhibits Inflammasome Assembly and Ameliorates Inflammatory Disease
- (2015) Lucia de Almeida et al. IMMUNITY
- The molecular mode of action and species specificity of canakinumab, a human monoclonal antibody neutralizing IL-1β
- (2015) Jean-Michel Rondeau et al. mAbs
- International experience of pregnancy outcomes in auto-inflammatory syndromes treated with Interleukin-1 inhibitors
- (2015) T Youngstein et al. Pediatric Rheumatology
- Canakinumab for the treatment of chronic obstructive pulmonary disease
- (2015) Paola Rogliani et al. PULMONARY PHARMACOLOGY & THERAPEUTICS
- Real-life effectiveness of canakinumab in cryopyrin-associated periodic syndrome
- (2015) Jasmin B. Kuemmerle-Deschner et al. RHEUMATOLOGY
- Musculoskeletal Symptoms in Patients With Cryopyrin-Associated Periodic Syndromes: A Large Database Study
- (2015) Laetitia Houx et al. Arthritis & Rheumatology
- Brief Report: Cryopyrin-Associated Periodic Syndrome Caused by a Myeloid-Restricted SomaticNLRP3Mutation
- (2015) Qing Zhou et al. Arthritis & Rheumatology
- A 24-month open-label study of canakinumab in neonatal-onset multisystem inflammatory disease
- (2014) Cailin H Sibley et al. ANNALS OF THE RHEUMATIC DISEASES
- Phenotypic and genotypic characteristics of cryopyrin-associated periodic syndrome: a series of 136 patients from the Eurofever Registry
- (2014) R Levy et al. ANNALS OF THE RHEUMATIC DISEASES
- Impaired cytokine responses in patients with cryopyrin-associated periodic syndrome (CAPS)
- (2014) M. H. Haverkamp et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Rilonacept for Gout Flare Prevention in Patients Receiving Uric Acid-lowering Therapy: Results of RESURGE, a Phase III, International Safety Study
- (2014) J. S. Sundy et al. JOURNAL OF RHEUMATOLOGY
- A novel human anti-interleukin-1β neutralizing monoclonal antibody showing in vivo efficacy
- (2014) Angeline XH Goh et al. mAbs
- The Effect of Rilonacept versus Placebo on Health-Related Quality of Life in Patients with Poorly Controlled Familial Mediterranean Fever
- (2014) Philip J. Hashkes et al. Biomed Research International
- Brief Report: Anakinra Use During Pregnancy in Patients With Cryopyrin-Associated Periodic Syndromes
- (2014) Zenas Chang et al. Arthritis & Rheumatology
- Randomized, Double-Blind, Placebo-Controlled Trial of the Efficacy and Safety of Rilonacept in the Treatment of Systemic Juvenile Idiopathic Arthritis
- (2014) Norman T. Ilowite et al. Arthritis & Rheumatology
- SomaticNLRP3mosaicism in Muckle-Wells syndrome. A genetic mechanism shared by different phenotypes of cryopyrin-associated periodic syndromes
- (2013) Kenji Nakagawa et al. ANNALS OF THE RHEUMATIC DISEASES
- Anakinra treatment in drug-resistant Behcet’s disease: a case series
- (2013) Luca Cantarini et al. CLINICAL RHEUMATOLOGY
- Impact of interleukin-1β antibody (canakinumab) on glycaemic indicators in patients with type 2 diabetes mellitus: Results of secondary endpoints from a randomized, placebo-controlled trial
- (2013) J. Hensen et al. DIABETES & METABOLISM
- Divergence of IL-1, IL-18, and cell death in NLRP3 inflammasomopathies
- (2013) Susannah D. Brydges et al. JOURNAL OF CLINICAL INVESTIGATION
- Interleukin-1 antagonism in type 1 diabetes of recent onset: two multicentre, randomised, double-blind, placebo-controlled trials
- (2013) Antoinette Moran et al. LANCET
- Failure of tocilizumab treatment in a CINCA patient: clinical and pathogenic implications
- (2013) L. S. Snegireva et al. RHEUMATOLOGY
- Efficacy and safety of canakinumab therapy in paediatric patients with cryopyrin-associated periodic syndrome: a single-centre, real-world experience
- (2013) R. A. G. Russo et al. RHEUMATOLOGY
- Treatment of Muckle-Wells syndrome: analysis of two IL-1-blocking regimens
- (2013) Jasmin B Kuemmerle-Deschner et al. ARTHRITIS RESEARCH & THERAPY
- The schedule of administration of canakinumab in cryopyrin associated periodic syndrome is driven by the phenotype severity rather than the age
- (2013) Roberta Caorsi et al. ARTHRITIS RESEARCH & THERAPY
- Efficacy of anakinra in gouty arthritis: a retrospective study of 40 cases
- (2013) Sébastien Ottaviani et al. ARTHRITIS RESEARCH & THERAPY
- Canakinumab in patients with cryopyrin-associated periodic syndrome: an update for clinicians
- (2013) Jasmin B. Kuemmerle-Deschner et al. Therapeutic Advances in Musculoskeletal Disease
- Efficacy and safety of the interleukin-1 antagonist rilonacept in Schnitzler syndrome: an open-label study
- (2012) K. Krause et al. ALLERGY
- Treatment of autoinflammatory diseases: results from the Eurofever Registry and a literature review
- (2012) Nienke ter Haar et al. ANNALS OF THE RHEUMATIC DISEASES
- Inflammasomes and Their Roles in Health and Disease
- (2012) Mohamed Lamkanfi et al. Annual Review of Cell and Developmental Biology
- Sustained response and prevention of damage progression in patients with neonatal-onset multisystem inflammatory disease treated with anakinra: A cohort study to determine three- and five-year outcomes
- (2012) Cailin H. Sibley et al. ARTHRITIS AND RHEUMATISM
- Effects of Interleukin-1β Inhibition With Canakinumab on Hemoglobin A1c, Lipids, C-Reactive Protein, Interleukin-6, and Fibrinogen
- (2012) Paul M Ridker et al. CIRCULATION
- Pharmacokinetic and Pharmacodynamic Properties of Canakinumab, a Human Anti-Interleukin-1β Monoclonal Antibody
- (2012) Abhijit Chakraborty et al. CLINICAL PHARMACOKINETICS
- Long-Term Efficacy and Safety Profile of Rilonacept in the Treatment of Cryopryin-Associated Periodic Syndromes: Results of a 72-Week Open-Label Extension Study
- (2012) Hal M. Hoffman et al. CLINICAL THERAPEUTICS
- Effects of Gevokizumab on Glycemia and Inflammatory Markers in Type 2 Diabetes
- (2012) C. Cavelti-Weder et al. DIABETES CARE
- Efficacy of anakinra in calcium pyrophosphate crystal-induced arthritis: A report of 16 cases and review of the literature
- (2012) Sébastien Ottaviani et al. JOINT BONE SPINE
- One Target—Two Different Binding Modes: Structural Insights into Gevokizumab and Canakinumab Interactions to Interleukin-1β
- (2012) Michaela Blech et al. JOURNAL OF MOLECULAR BIOLOGY
- Interleukin-1β inhibition and the prevention of recurrent cardiovascular events: Rationale and Design of the Canakinumab Anti-inflammatory Thrombosis Outcomes Study (CANTOS)
- (2011) Paul M Ridker et al. AMERICAN HEART JOURNAL
- Two-year results from an open-label, multicentre, phase III study evaluating the safety and efficacy of canakinumab in patients with cryopyrin-associated periodic syndrome across different severity phenotypes
- (2011) J. B. Kuemmerle-Deschner et al. ANNALS OF THE RHEUMATIC DISEASES
- High incidence of NLRP3 somatic mosaicism in patients with chronic infantile neurologic, cutaneous, articular syndrome: Results of an international multicenter collaborative study
- (2011) Naoko Tanaka et al. ARTHRITIS AND RHEUMATISM
- Interleukin-1 in the pathogenesis and treatment of inflammatory diseases
- (2011) C. A. Dinarello BLOOD
- XOMA 052, a potent, high-affinity monoclonal antibody for the treatment of IL-1β-mediated diseases
- (2011) Alexander M. Owyang et al. mAbs
- Canakinumab (ACZ885, a fully human IgG1 anti-IL-1β mAb) induces sustained remission in pediatric patients with cryopyrin-associated periodic syndrome (CAPS)
- (2011) Jasmin B Kuemmerle-Deschner et al. ARTHRITIS RESEARCH & THERAPY
- Efficacy and long-term follow-up of IL-1R inhibitor anakinra in adults with Still's disease: a case-series study
- (2011) Katerina Laskari et al. ARTHRITIS RESEARCH & THERAPY
- Sustained remission of symptoms and improved health-related quality of life in patients with cryopyrin-associated periodic syndrome treated with canakinumab: results of a double-blind placebo-controlled randomized withdrawal study
- (2011) Isabelle Koné-Paut et al. ARTHRITIS RESEARCH & THERAPY
- Mutations in the autoinflammatory cryopyrin-associated periodic syndrome gene: epidemiological study and lessons from eight years of genetic analysis in France
- (2010) L. Cuisset et al. ANNALS OF THE RHEUMATIC DISEASES
- Efficacy and safety of anakinra therapy in pediatric and adult patients with the autoinflammatory Muckle-Wells syndrome
- (2010) Jasmin B. Kuemmerle-Deschner et al. ARTHRITIS AND RHEUMATISM
- Kinetic Approach to Pathway Attenuation Using XOMA 052, a Regulatory Therapeutic Antibody That Modulates Interleukin-1β Activity
- (2010) Marina K. Roell et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The serum and cerebrospinal fluid pharmacokinetics of anakinra after intravenous administration to non-human primates
- (2010) Elizabeth Fox et al. JOURNAL OF NEUROIMMUNOLOGY
- Follow-Up and Quality of Life of Patients with Cryopyrin-Associated Periodic Syndromes Treated with Anakinra
- (2010) Loredana Lepore et al. JOURNAL OF PEDIATRICS
- Effect of anakinra on arthropathy in CINCA/NOMID syndrome
- (2010) Takako Miyamae et al. Pediatric Rheumatology
- Altered redox state of monocytes from cryopyrin-associated periodic syndromes causes accelerated IL-1 secretion
- (2010) S. Tassi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Horror Autoinflammaticus: The Molecular Pathophysiology of Autoinflammatory Disease
- (2009) Seth L. Masters et al. Annual Review of Immunology
- The Inflammasomes: Guardians of the Body
- (2009) Fabio Martinon et al. Annual Review of Immunology
- Immunological and Inflammatory Functions of the Interleukin-1 Family
- (2009) Charles A. Dinarello Annual Review of Immunology
- Long-term efficacy of the interleukin-1 receptor antagonist anakinra in ten patients with neonatal-onset multisystem inflammatory disease/chronic infantile neurologic, cutaneous, articular syndrome
- (2009) Bénédicte Neven et al. ARTHRITIS AND RHEUMATISM
- Rilonacept for the treatment of cryopyrin-associated periodic syndromes (CAPS)
- (2009) Hal M Hoffman EXPERT OPINION ON BIOLOGICAL THERAPY
- In vivo regulation of interleukin 1β in patients with cryopyrin-associated periodic syndromes
- (2009) Helen J. Lachmann et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Use of Canakinumab in the Cryopyrin-Associated Periodic Syndrome
- (2009) Helen J. Lachmann et al. NEW ENGLAND JOURNAL OF MEDICINE
- A pilot study to evaluate the safety and efficacy of the long-acting interleukin-1 inhibitor rilonacept (interleukin-1 trap) in patients with familial cold autoinflammatory syndrome
- (2008) Raphaela Goldbach-Mansky et al. ARTHRITIS AND RHEUMATISM
- Efficacy and safety of rilonacept (interleukin-1 trap) in patients with cryopyrin-associated periodic syndromes: Results from two sequential placebo-controlled studies
- (2008) Hal M. Hoffman et al. ARTHRITIS AND RHEUMATISM
- Cryopyrin-associated periodic syndromes: development of a patient-reported outcomes instrument to assess the pattern and severity of clinical disease activity
- (2008) Hal M. Hoffman et al. CURRENT MEDICAL RESEARCH AND OPINION
- The human anti-IL-1β monoclonal antibody ACZ885 is effective in joint inflammation models in mice and in a proof-of-concept study in patients with rheumatoid arthritis
- (2008) Rieke Alten et al. ARTHRITIS RESEARCH & THERAPY
- Cryopyrinopathies: update on pathogenesis and treatment
- (2008) Bénédicte Neven et al. Nature clinical practice. Rheumatology
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started